Health

Coronavirus drug shows promise at Carolina

Potential relief to the coronavirus pandemic.

Potential relief to the coronavirus pandemic.

UNC Gillings School of Global Public Health researchers are testing a new broad-spectrum antiviral drug that could potentially be a relief to the global coronavirus pandemic.

Ralph Baric, an epidemiologist in the Gillings School of Global Public Health, heads a lab testing a broad-spectrum antiviral drug called remdesivir. 

Six years ago, the lab partnered with the biopharmaceutical company Gilead Sciences Inc. Their goal was testing the company’s antiviral drugs to curb emerging viral diseases often overlooked by big pharmaceutical companies, said Tim Sheahan, a virologist in Baric’s lab.

Coronaviruses were of particular interest. Fast forward to today, and the intravenous drug remdesivir could potentially be a relief to this global pandemic. Just like broad-spectrum antibiotics — which can cure a wide range of bacterial infections — a broad-spectrum antiviral like remdesivir can work against genetically distinct viruses.

Read the complete Carolina Story…Opens in new window

UNC Gillings School of Global Public Health Funding Priorities

Readers Also Viewed...

Research

Making Progress

A drug with potential to treat COVID-19 symptoms is moving to human clinical trials.

Health

Mitigating the Coronavirus

Preventing the spread of Covid-19

Health

Obesity: One Size Does Not Fit All

Encouraging innovation and team science

Health

The Enhanced Baby Bundle

“This project has the potential to impact 178,000 births every year in the Carolinas.”

Aaron Salzberg
Leadership

Changing the Way the World Works on Water

“UNC has a long history of producing world leaders in water.”

Global Impact

Making Childbirth Safer for Mothers Worldwide

“In many parts of the world, the days surrounding childbirth are the riskiest period a mother and her newborn will ever face.”